Caris Life Sciences (CAI) EPS (Basic) (2024 - 2026)

Caris Life Sciences' (CAI) quarterly EPS (Basic) came in at -$0.0 in Q1 2026, up 99.95% year-on-year from -$0.0 in Q1 2025, and down 100.37% quarter-over-quarter from $0.49 in Q4 2025.

Caris Life Sciences (CAI) EPS (Basic) (2024 - 2026) Analysis & Trends

Caris Life Sciences' EPS (Basic) history runs 3 years deep, the most recent figure standing at -$0.0 for Q1 2026.

  • On a quarterly basis, EPS (Basic) rose 99.95% year-over-year to -$0.0 in Q1 2026; TTM through Mar 2026 was -$1.46, a 86.03% increase from a year earlier, with the FY2025 full-year figure at -$3.22, up 69.81% from the prior year.
  • EPS (Basic) retreated to -$0.0 in Q1 2026 per CAI's latest filing, from $0.49 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $0.49 in Q4 2025 and bottomed at -$7.97 in Q2 2025.
  • The 3-year median for EPS (Basic) is -$2.14 (2024), against an average of -$2.23.
  • Biggest YoY gain for EPS (Basic) was 128.09% in 2025; the steepest drop was 213.88% in 2025.
  • Year by year, EPS (Basic) stood at -$1.75 in 2024, then jumped by 128.09% to $0.49 in 2025, then plunged by 100.37% to -$0.0 in 2026.
  • Per Business Quant, the three latest CAI EPS (Basic) figures stand at -$0.0 (Q1 2026), $0.49 (Q4 2025), and $0.09 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 0.00
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 0.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.16
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 6.99
7 Belite Bio 61.40 Bn 61.40 Bn - 0.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 5.90
9 Revolution Medicines 37.37 Bn 37.37 Bn - -2.29
10 Caris Life Sciences 4.35 Bn 3.53 Bn 214.23 Mn 0.00

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.49
Sep 30, 2025 0.09
Jun 30, 2025 -7.97
Mar 31, 2025 -3.57
Dec 31, 2024 -1.75
Sep 30, 2024 -2.59
Jun 30, 2024 -2.54